Vectalys will be exhibiting at MipTec conference in September 20-24, 2010 (Basel, Switzerland).

Our team will be present in the exhibition hall booth n° G08.
MipTec is the leading European conference and exhibition for drug discovery technologies.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it for further details or for a presentation of our services.

Vectalys will attend for the first time the Society for Biomolecular Sciences 16^th annual congress taking place in April 11-15, 2010 (Phoenix, Arizona).

Dr Pascale Bouillé, Vectalys CEO, is selected as speaker in the session “Critical Reagents: Strategies for Library Design, Biological Tools, & Process Logistics” (Track 3, Tuesday, April 13). The topic of her presentation will be  "Viral Vectors, Novel Tools in Drug Discovery for Cell and Animal Engineering".

Vectalys team will also be present in the exhibition hall booth n° 421  and will be pleased to present the company’s services. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it to organize a meeting.

UROsphere and Vectalys selected by the SISMIP for their research program «Novel gene targets discovery for prostatic pathologies ».

Vectalys and UROsphere (a company specialized in urologic deseases) are pleased to announce the selection of the research programme « Discovery of new targets for prostatic pathologies ». This program has been retained through an innovative project call organized by SISMIP (Health Industries Network in the Midi-Pyrenees Region) and DRIRE Midi-Pyrenees (Regional Board for Industries, Research and Environment).
Both companies will work together on the programme for 1 year.

The 3SI program for Innovation in the Health Sector is a call for innovative projects reserved to SMEs located in Midi-Pyrenees Region. This program is also supported by the Regional Board of OSEO (France's national agency for industrial innovation), the Regional Board for Research and Technology (DRRT), the Cancer-Bio-Health cluster and Midi Pyrénées Innovation (MPI).